Commentary
Commentary
Niacin's effect on cardiovascular risk: Have we finally learned our lesson?
For now, the renaissance of niacin as a means of lowering cardiovascular risk is only wishful thinking.
Commentary
New cholesterol guidelines: Worth the wait?
An appraisal of the controversial new guidelines, with case scenarios illustrating their advantages and shortcomings.
Commentary
The conundrum of explaining breast density to patients
Several states have mandated that, after mammography, patients be informed if their breasts are dense. Explaining what this means is a challenge...
Commentary
The overdiagnosis of pneumonia
We are hospitalizing more patients with "pneumonia," but it has not improved outcomes.
Commentary
Azithromycin and risk of sudden cardiac death: Guilty as charged or falsely accused?
We need not abandon this drug, but we should see if our patients have risk factors, and take precautions.
Commentary
Electronic siloing: An unintended consequence of the electronic health record
For all their purported benefits, electronic systems drive caregivers to work alone, thereby discouraging spontaneous interaction.
Commentary
Should healthy people take calcium and vitamin D to prevent fractures? What the US Preventive Services Task Force and others say
The USPSTF recently threw cold water on the use of these supplements, but the findings need to be put in context.
Commentary
The 2012 ACR guidelines for osteoarthritis: Not a cookbook
Treatment approaches differ depending on the patient's clinical presentation and on the preferences of the patient and the physician. Often, more...
Commentary
The conundrum of cost-effectiveness
The author of the commentary replies.
Commentary
The apples and oranges of cost-effectiveness: A rejoinder
A recent CCJM commentary used straw men to indict cost-effectiveness research.